Literature DB >> 10080860

The influence of a targeted deletion of the IFNgamma gene on emotional behaviors.

Y Kustova1, Y Sei, H C Morse, A S Basile.   

Abstract

Evidence suggests that interferon-gamma (IFNgamma) plays an important role in CNS function and development. While the paucity of agents that selectively modify IFNgamma production or interaction with its receptors makes analyses of its potential behavioral relevance difficult, mice with null mutations of the IFNgamma gene have been used to investigate the potential role of IFNgamma in emotional behaviors. C57Bl/6 (B6) mice with null mutations of the IFNgamma gene (IFNgamma (-/-)) showed significantly increased emotionality compared to the wild-type (IFNgamma (+/+)) B6 mice. This was manifested in performance in the elevated plus maze as well as increased defecation scores and decreased locomotor activity both in novel environments and following a sonic stimulus. In contrast, the general level of emotionality of both IFNgamma (+/+) and (-/-) BALB/c (C) mice was substantially greater than that of either of the B6 mouse groups. While C IFNgamma (-/-) showed increased immobility in response to novelty, other indices of emotionality of C IFNgamma (-/-) mice were not significantly different from those of the C IFNgamma (+/+) mice. In summary, the lack of IFNgamma appears to contribute to increased emotionality, but the basal behaviors of the parental strain (e.g., BALBc) may overshadow the expression of this emotionality. While mice with null mutations of the IFNgamma gene may be useful tools for investigating the role of IFNgamma in brain function and behavior, the influence of the parent strain genome(s) on the behaviors in question must be taken into account. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10080860     DOI: 10.1006/brbi.1998.0546

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  13 in total

1.  Reduced fear memory and anxiety-like behavior in mice lacking formylpeptide receptor 1.

Authors:  Ji-Liang Gao; Erich H Schneider; Eugene L Dimitrov; Forrest Haun; Therese M Pham; Abdul H Mohammed; Ted B Usdin; Philip M Murphy
Journal:  Behav Genet       Date:  2011-04-12       Impact factor: 2.805

2.  Circulating cytokine levels are associated with symptoms of depression and anxiety among people with alcohol and drug use disorders.

Authors:  Priscilla Martinez; Lars Lien; Sarah Zemore; Jørgen G Bramness; Sudan Prasad Neupane
Journal:  J Neuroimmunol       Date:  2018-02-22       Impact factor: 3.478

Review 3.  Molecular pathways of anxiety revealed by knockout mice.

Authors:  S J Wood; M Toth
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

Review 4.  Genetic and environmental factors interact to influence anxiety.

Authors:  Cornelius Gross; René Hen
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 5.  Microglial Inflammatory-Metabolic Pathways and Their Potential Therapeutic Implication in Major Depressive Disorder.

Authors:  Reza Rahimian; Claudia Belliveau; Rebecca Chen; Naguib Mechawar
Journal:  Front Psychiatry       Date:  2022-06-16       Impact factor: 5.435

6.  Immune Endophenotypes in Children With Autism Spectrum Disorder.

Authors:  Milo Careaga; Sally Rogers; Robin L Hansen; David G Amaral; Judy Van de Water; Paul Ashwood
Journal:  Biol Psychiatry       Date:  2015-09-11       Impact factor: 13.382

Review 7.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

8.  Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers.

Authors:  Christine Miaskowski; Janine K Cataldo; Christina R Baggott; Claudia West; Laura B Dunn; Anand Dhruva; John D Merriman; Dale J Langford; Kord M Kober; Steven M Paul; Bruce A Cooper; Bradley E Aouizerat
Journal:  Support Care Cancer       Date:  2014-09-24       Impact factor: 3.603

9.  The clinical implications of mouse models of enhanced anxiety.

Authors:  Simone B Sartori; Rainer Landgraf; Nicolas Singewald
Journal:  Future Neurol       Date:  2011-07-01

10.  Oxidative imbalance and anxiety disorders.

Authors:  Krolow R; Arcego D M; Noschang C; Weis S N; Dalmaz C
Journal:  Curr Neuropharmacol       Date:  2014-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.